I for one, can't disagree...
They do need to get much much better on that side...While the science continues to literally stun me ....we need more than that to bring this to ample fruition.
Im well aware things can and sometimes SHOULD change...hellllloo Adaptive clinical trials!I understand that there were prob a lot more to it..close off on trials, other unanticipated expenses, bringing costs possibly forward to progress quickly to next stage, having to listen to what the FDA want/need...what consultants were saying best practices whatever... But that was a lot to digest...specially on the back of a CR.
Yes I as a mere sh am expressing it in whatever I can do.
I for one, can't disagree...They do need to get much much better...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.0¢ | $122.3K | 521.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 330565 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |